[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632413":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":11,"centralContacts":23,"locations":29,"responsibleParty":47,"collaborators":11,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":11,"eligibilityCriteria":57,"healthyVolunteers":58,"sex":59,"minAge":11,"maxAge":60,"enrollmentInfo":61,"targetDuration":11,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":11,"overallStatus":71,"whyStopped":11,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Marmara University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Overactive Bladder Group","ACTIVE_COMPARATOR",null,[13],"Behavioral: Urotherapy",{"label":15,"type":16,"description":11,"interventionNames":11},"Healthy Group","NO_INTERVENTION",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":11},"BEHAVIORAL","Urotherapy","Diagnosis and first-line treatment (urotherapy) will be conducted per European Association of Urology (EAU) guidelines.",[9],[24],{"name":25,"role":26,"phone":27,"phoneExt":11,"email":28},"Hamza Tunahan Midilli","CONTACT","905449695848","hamzamidilli@gmail.com",[30],{"facility":31,"status":11,"city":32,"state":33,"zip":34,"country":35,"countryCode":11,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Marmara University School of Medicine Urology Department","Pendik","Istanbul","34100","Turkey (Türkiye)",{"type":37,"coordinates":38},"Point",[39,40],29.2725,40.8775,{"lat":40,"lon":39},[43],{"name":44,"role":26,"phone":45,"phoneExt":11,"email":46},"Cagri Akin Sekerci","05344525700","cagri_sekerci@hotmail.com",{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"SPONSOR_INVESTIGATOR","Tarik Emre Sener","Associated Professor","100632413","the-role-of-urinary-rhoa-ngf-and-bdnf-levels-in-overactive-bladder-and-vitamin-d-deficiency-100632413",false,"NCT07513363","The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency","The Role of Urinary RhoA, NGF, and BDNF Levels in Diagnosis and Follow-up in Children With Overactive Bladder and Vitamin D Deficiency.","Inclusion Criteria:\n\n* Children aged 4-18 years presenting with active OAB symptoms (frequency, urgency)\n\nExclusion Criteria:\n\n* Neurological diseases\n* Malignancy\n* Active urinary tract infections\n* Anatomical bladder anomalies\n* History of prior OAB treatment\u002Furological surgery.",true,"ALL","18 Years",{"count":62,"type":63},52,"ESTIMATED","INTERVENTIONAL",[66],"NA","The primary aim of this study is to evaluate the role of three specific urinary proteins-RhoA, Nerve Growth Factor (NGF), and Brain-Derived Neurotrophic Factor (BDNF)-as potential biomarkers for the diagnosis and follow-up of children aged 4-18 diagnosed with Overactive Bladder (OAB) and Vitamin D deficiency.",[69,70],"Overactive Bladder","Vitamin D Deficiency","NOT_YET_RECRUITING","2026-04-01",{"date":74,"type":75},"2026-04-07","ACTUAL",{"date":77,"type":63},"2026-05-01",{"date":79,"type":63},"2027-01-01",{"name":49,"class":6},1]